InSyBio News

InSyBio, a leader in artificial intelligence-powered bioinformatics and precision medicine solutions, today announced the launch of BioInfoLLM™, a domain-specific artificial intelligence assistant integrated into the InSyBio Suite. Designed specifically for bioinformatics, multi-omics analysis, and biomarker discovery, BioInfoLLM enables researchers to interact with complex computational workflows through natural language while providing scientifically grounded guidance throughout the…Continue reading→

InSyBio is pleased to announce the publication of a new scientific study titled “Intratumoral collagen correlates with histological grade and patient prognosis in breast cancer” in Experimental and Molecular Pathology. Breast cancer development and clinical progression are influenced not only by cancer cells but also by the surrounding tumor microenvironment. The extracellular matrix, and collagen…Continue reading→

InSyBio is happy to announce a new scientific publication titled “Dual Role of Cancer Epithelial-Specific TRAF3 in Regulating Breast Cancer Cell Survival and Lymphocyte Activity,” published in International Journal of Molecular Sciences. We would like to congratulate all the authors, Chaido Sirinian, Anne-Lise de Lastic, Harry Zaverdas, Martha Nifora, Dimitra Georgakopoulou, Martina Samiotaki, Maria Ioanna…Continue reading→

InSyBio is happy to announce a new scientific publication titled “Biomimetic characterization by micro-computed tomography (μCT) of 3D hollow fibre membrane network bioreactors for tissue engineering,” authored by Giuseppe Falvo D’Urso Labate, Chiara Morano, Thomas De Schryver, Harry Zaverdas, Luigi De Napoli, Gionata Fragomeni, Luc Van Hoorebeke, Patrick Segers, Mathieu Boone, Konstantinos Theofilatos, Joerg Christian…Continue reading→

InSyBio has been selected to join the ScaleUps Studio track of the Start4Health programme, an initiative led by Pfizer’s Center for Digital Innovation (CDI). This selection represents an important milestone for the company and further reinforces its position within the digital health innovation ecosystem. Start4Health is designed to connect innovative companies with Pfizer’s innovation ecosystem…Continue reading→

InSyBio is happy to announce a new scientific publication led by Filip Stojceski, titled “Molecular-level understanding of the aging bone and regeneration mechanisms using computational methods”, published in Osteoporosis International. The article is available as an open-access publication (https://doi.org/10.1007/s00198-026-07903-z )and was developed in the context of the REGENERATION project. The publication provides a comprehensive review…Continue reading→

InSyBio has been accepted into the A4SUSTINNO accelerator programme, a significant step in the company’s innovation and growth trajectory and an important opportunity to further strengthen its activities in the fields of bioinformatics, artificial intelligence, and digital health. The A4SUSTINNO accelerator is a free acceleration programme addressed to startups and teams active in the digital…Continue reading→

InSyBio participated in the midterm meeting of the GALATEA Horizon Europe Project, which took place in Athens on 11–12 March 2026 at the Athena Research Center. The meeting marked an important milestone in the implementation of the project and brought together consortium partners from across Europe to review the progress achieved during the first phase…Continue reading→

InSyBio is thrilled to announce the release of InSyBio Suite Version 3.4, with a major upgrade to the InSyBio Interact tool, an advanced environment for protein analysis, protein–protein interaction (PPI) information retrieval, functional annotation, and biological network creation. InSyBio Interact v3.4 features improved PPI search capabilities supported by a comprehensive database of more than 2…Continue reading→

A unique Machine-Learning and Molecular Modelling pipeline focusing on the interactome of the Taste Receptors has been released in a new publication from the InSyBio team in collaboration with a team of exceptional researchers from Dalle Molle Institute for Artificial Intelligence (Switzerland), and Politecnico di Torino (Italy) in the framework of VIRTUOUS Project, an EU…Continue reading→